Blood Pressure and Leg Deoxygenation Are Exaggerated During Treadmill Walking in Patients with Peripheral Artery Disease
Overview
Authors
Affiliations
The purpose of this study was to investigate blood pressure (BP) and leg skeletal muscle oxygen saturation (Smo) during treadmill walking in patients with peripheral artery disease (PAD) and healthy subjects. Eight PAD patients (66 ± 8 yr, 1 woman) and eight healthy subjects (65 ± 7 yr, 1 woman) walked on a treadmill at 2 mph (0.89 m/s). The incline increased by 2% every 2 min, from 0 to 15% or until maximal discomfort. BP was measured every 2 min with an auscultatory cuff. Heart rate (HR) was recorded continuously with an ECG. Smo in the gastrocnemius muscle was measured on each leg using near-infrared spectroscopy. The change in systolic BP from seated to peak walking time (PWT) was greater in PAD (healthy: 23 ± 9 vs. PAD: 44 ± 19 mmHg, = 0.007). HR was greater in PAD patients compared with controls at PWT ( = 0.011). The reduction in Smo (PWT - seated) was greater in PAD (healthy: 15 ± 12 vs. PAD: 49 ± 5%, < 0.001) in the most affected leg and in the least affected leg (healthy: 12 ± 11 vs. PAD: 32 ± 18%, = 0.003). PAD patients have an exaggerated decline in leg Smo during walking compared with healthy subjects, which may elicit the exaggerated rise in BP and HR during walking in PAD. This is the first study to simultaneously measure skeletal muscle oxygen saturation and blood pressure (BP) during treadmill exercise in patients with peripheral arterial disease. We found that BP and leg deoxygenation responses to slow-paced, graded treadmill walking are greater in patients with peripheral arterial disease compared with healthy subjects. These data may help explain the high cardiovascular risk in patients with peripheral arterial disease.
Measurement of Revascularization Effect Using Near Infrared Spectroscopy in Below the Knee Arteries.
Baltrunas T, Pikturnaite G, Racyte A, Baltruniene V, Mosenko V, Skrebunas A Rev Cardiovasc Med. 2024; 23(9):299.
PMID: 39077693 PMC: 11262333. DOI: 10.31083/j.rcm2309299.
Butenas A, Flax J, Carroll R, Chuwonganant C, Baranczuk A, Copp S Am J Physiol Regul Integr Comp Physiol. 2024; 326(6):R449-R460.
PMID: 38497127 PMC: 11381033. DOI: 10.1152/ajpregu.00010.2024.
Neurocirculatory regulation and adaptations to exercise in chronic kidney disease.
Sprick J, Jeong J, Sabino-Carvalho J, Li S, Park J Am J Physiol Heart Circ Physiol. 2023; 324(6):H843-H855.
PMID: 37000610 PMC: 10191135. DOI: 10.1152/ajpheart.00115.2023.
Butenas A, Rollins K, Williams A, Copp S Am J Physiol Regul Integr Comp Physiol. 2022; 324(2):R183-R195.
PMID: 36534589 PMC: 9886358. DOI: 10.1152/ajpregu.00274.2022.
Arkoudis N, Katsanos K, Inchingolo R, Paraskevopoulos I, Mariappan M, Spiliopoulos S World J Cardiol. 2021; 13(9):381-398.
PMID: 34621485 PMC: 8462037. DOI: 10.4330/wjc.v13.i9.381.